imedisync's portable EEG device, validated by Seoul National University research, offers quantitative brainwave analysis. User-friendly and portable, it aids clinicians in assessing patients, facilitating telemedicine and personalized mental healthcare. FDA 510(k) approval is sought. there have been many studies on biomarkers of neuropsychological problems slowing off alpha peak frequency suggests cognitive decline beta spindling is strongly associated with anxiety or insomnia and in 2013 the FDA approved the first EEG-based biomarker of ADHD by computing the theta beta ratio we are discovering new neuromarkers uh, by the day.